PAPER Fonseca LC, Tedrus GM, Fondello MA, Reis IN, Fontoura DS
SEARCH RESULTS
331254 RESULTS
PAPER Khairallah MI, Kassem LA
Alzheimer's disease: current status of etiopathogenesis and therapeutic strategies.
Pak J Biol Sci. 2011 Feb 15;14(4):257-72. PubMed: 21870628PAPER
Diabetes drug could work against Alzheimer's, animal study suggests.
Clin EEG Neurosci. 2011 Jul;42(3):190-4. PubMed: 21870651PAPER Geldenhuys WJ, Van der Schyf CJ
Role of serotonin in Alzheimer's disease: a new therapeutic target?
CNS Drugs. 2011 Sep 1;25(9):765-81. PubMed: 21870888PAPER Pramanik D, Ghosh C, Dey SG
Heme-Cu bound aβ peptides: spectroscopic characterization, reactivity, and relevance to Alzheimer's disease.
J Am Chem Soc. 2011 Oct 5;133(39):15545-52. PubMed: 21870836PAPER Bar-Or A, Rieckmann P, Traboulsee A, Yong VW
Targeting progressive neuroaxonal injury: lessons from multiple sclerosis.
CNS Drugs. 2011 Sep 1;25(9):783-99. PubMed: 21870889PAPER Amniai L, Lippens G, Landrieu I
Characterization of the AT180 epitope of phosphorylated Tau protein by a combined nuclear magnetic resonance and fluorescence spectroscopy approach.
Biochem Biophys Res Commun. 2011 Sep 9;412(4):743-6. PubMed: 21871442PAPER Koffie RM, Hyman BT, Spires-Jones TL
Alzheimer's disease: synapses gone cold.
Mol Neurodegener. 2011;6(1):63. PubMed: 21871088PAPER Tomono S, Miyoshi N, Ito M, Higashi T, Ohshima H
A highly sensitive LC-ESI-MS/MS method for the quantification of cholesterol ozonolysis products secosterol-A and secosterol-B after derivatization with 2-hydrazino-1-methylpyridine.
J Chromatogr B Analyt Technol Biomed Life Sci. 2011 Sep 15;879(26):2802-8. PubMed: 21871845PAPER Mao P, Reddy PH
Aging and amyloid beta-induced oxidative DNA damage and mitochondrial dysfunction in Alzheimer's disease: implications for early intervention and therapeutics.
Biochim Biophys Acta. 2011 Nov;1812(11):1359-70. PubMed: 21871956PAPER Grimm MO, Grösgen S, Riemenschneider M, Tanila H, Grimm HS, Hartmann T
From brain to food: analysis of phosphatidylcholins, lyso-phosphatidylcholins and phosphatidylcholin-plasmalogens derivates in Alzheimer's disease human post mortem brains and mice model via mass spectrometry.
J Chromatogr A. 2011 Oct 21;1218(42):7713-22. PubMed: 21872257PAPER Huang H, Fan X, Weiner M, Martin-Cook K, Xiao G, Davis J, Devous M, Rosenberg R, Diaz-Arrastia R
Distinctive disruption patterns of white matter tracts in Alzheimer's disease with full diffusion tensor characterization.
Neurobiol Aging. 2011 Aug 26; PubMed: 21872362PAPER Liu RT, Tang JT, Zou LB, Fu JY, Lu QJ
Liquiritigenin attenuates the learning and memory deficits in an amyloid protein precursor transgenic mouse model and the underlying mechanisms.
Eur J Pharmacol. 2011 Nov 1;669(1-3):76-83. PubMed: 21872584PAPER Mizuno T, Doi Y, Mizoguchi H, Jin S, Noda M, Sonobe Y, Takeuchi H, Suzumura A
Interleukin-34 selectively enhances the neuroprotective effects of microglia to attenuate oligomeric amyloid-β neurotoxicity.
Am J Pathol. 2011 Oct;179(4):2016-27. PubMed: 21872563PAPER Lasagna-Reeves CA, Kayed R
Astrocytes contain amyloid-β annular protofibrils in Alzheimer's disease brains.
FEBS Lett. 2011 Oct 3;585(19):3052-7. PubMed: 21872592Current Filters
No filters selected